BIAF: Positive Preclinical Findings
BIAF bioAffinity Technologies reports positive preclinical findings showing proprietary gene silencing technology is selectively cytotoxic to squamous skin cancer cells without harming healthy cells
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.